Jesse Shefferman - 21 Jan 2025 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Role
CEO and President, Director
Signature
/s/ Jesse Shefferman
Issuer symbol
TARA
Transactions as of
21 Jan 2025
Net transactions value
-$73,632
Form type
4
Filing time
23 Jan 2025, 16:05:19 UTC
Previous filing
07 Jan 2025
Next filing
28 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARA Common Stock Tax liability $73,632 -15,469 -1.7% $4.76 913,553 21 Jan 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards granted to the Reporting Person on January 19, 2023 and January 19, 2024.